Malaysia - Inggris - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - clomipramine hydrochloride -

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

zr pharma& gmbh - clomipramine hydrochloride - prolonged-release tablet - 75 milligram(s) - non-selective monoamine reuptake inhibitors; clomipramine

Malta - Inggris - Medicines Authority

pharmaand gmbh taborstrasse 1 1020 vienna , austria - clomipramine hydrochloride - coated tablet - clomipramine hydrochloride 10 mg - psychoanaleptics

Malta - Inggris - Medicines Authority

pharmaand gmbh taborstrasse 1 1020 vienna , austria - clomipramine hydrochloride - coated tablet - clomipramine hydrochloride 25 mg - psychoanaleptics

Malta - Inggris - Medicines Authority

pharmaand gmbh taborstrasse 1 1020 vienna , austria - clomipramine hydrochloride - prolonged-release tablet - clomipramine hydrochloride 75 mg - psychoanaleptics

Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - chlorantraniliprole(200g/l)+clothianidin(500g/kg) - insecticide

Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - chlorantraniliprole(350g/kg) - group 28 insecticide

Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - chlorantraniliprole(350g/kg) - group 28 insecticide

Amerika Serikat - Inggris - NLM (National Library of Medicine)

geigy pharmaceuticals - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - injection, solution - 25 mg in 2 ml - depression : for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. initial dosage should be low and increases should be gradual and cautiously prescribed. the drug is contraindicated during the acute recovery period after a myocardial infarction. patients with a known hypersensitivity to this compound should not be given the drug. the possibility of cross-sensitivity to other dibenzazepine compounds should be k

Selandia Baru - Inggris - Ministry for Primary Industries

fmc new zealand limited - chlorantraniliprole - chlorantraniliprole 350 g/kg - insecticide